STERIS plc (STE) Azione Prezzo
STERIS plc Prezzo
Il fatturato è cresciuto a un tasso composto del 8,8% annuo negli ultimi 19 anni, raggiungendo 5,94 miliardi USD. L'utile per azione è cresciuto del 10,1% all'anno negli ultimi 19 anni. Il margine netto di STERIS plc si attesta al 13,2%, in aumento rispetto al 5,8% di alcuni anni fa. STERIS plc offre attualmente un rendimento da dividendo di circa il 1,06%. Il payout ratio è pari a circa il 93% degli utili. Il dividendo è cresciuto del 13,5% all'anno negli ultimi 19 anni. Gli analisti fissano un target di prezzo mediano di 270,00 USD, ovvero il 16,2% sopra il prezzo attuale. Su 13 analisti, 9 valutano il titolo come acquisto — nel complesso un consenso Acquistare.
STERIS plc Prezzo delle azioni
Accedi a questi dati tramite l’API Eulerpool
100.000 richieste/mese gratis · nessuna carta di credito
STERIS plc Azione e analisi azionaria
Domande frequenti sull'azione STERIS plc
The business model of Steris plc revolves around providing innovative and comprehensive solutions in the healthcare industry. As a global leader, Steris plc focuses on offering products and services that enhance infection prevention, sterilization, and surgical efficiency. With a wide range of offerings including equipment, consumables, and software solutions, Steris plc aims to improve patient outcomes and increase operational productivity for hospitals and healthcare facilities worldwide. Their dedication to advanced technologies and patient safety has earned them a strong reputation in the industry.
Steris plc is primarily active in the healthcare industry. As a global leader, Steris provides innovative solutions and products focused on infection prevention, cleaning, and sterilization for healthcare facilities. With a wide range of offerings, Steris caters to hospitals, ambulatory surgical centers, pharmaceutical companies, and other healthcare institutions. By leveraging its expertise and advanced technologies, Steris aims to enhance patient safety, improve operational efficiency, and support healthcare professionals in delivering high-quality care.
The main competitors of Steris plc in the market include companies such as Johnson & Johnson, 3M Company, and Cantel Medical Corp. These companies operate in the same sector as Steris plc and provide similar products and services. However, Steris plc stands out due to its strong position in the market, diverse product portfolio, and robust customer base. With its innovative solutions and consistent focus on customer satisfaction, Steris plc continues to stay ahead of its competitors in the industry.
Steris plc is a leading global provider of infection prevention and surgical products, services, and technologies. The company was founded in 1985 as Innovative Medical Technologies and later changed its name to Steris Corporation. In 2015, Steris Corporation merged with Synergy Health plc to become Steris plc. With a rich history spanning over three decades, Steris plc has been dedicated to advancing healthcare and related industries. The company offers a wide range of solutions, including sterilization systems, surgical tables, detergents, and disinfectants. Steris plc has established itself as a trusted name in the medical and life sciences sectors, constantly striving to enhance patient safety and improve healthcare outcomes.
Steris plc, a leading company in the medical technology field, has achieved several significant milestones over the years. One noteworthy accomplishment is the acquisition of Synergy Health, which allowed Steris plc to expand its product portfolio and strengthen its global presence. Additionally, the company made strides in research and development, launching innovative solutions such as the Sterrad NX and System 1E, which revolutionized sterilization practices in healthcare settings. Steris plc also gained recognition for its commitment to quality, receiving ISO 9001 certification for its manufacturing facilities. These milestones highlight Steris plc's dedication to delivering advanced and reliable medical technology solutions to its customers worldwide.
Steris plc is primarily present in several countries and regions around the world. As a global company, Steris plc has a significant presence in the United States, where it is headquartered. It also operates in various regions including Europe, Asia, and Latin America. The company's international presence allows it to serve a diverse range of customers and expand its market reach. With a strong focus on providing innovative infection prevention and sterilization solutions, Steris plc continues to establish itself as a leader in the healthcare and life sciences industries worldwide.
Steris plc is a global leader in infection prevention, sterilization, and surgical products and services. The values and corporate philosophy that define Steris plc revolve around their commitment to enhancing healthcare safety and improving the quality of patient care. The company focuses on delivering innovative solutions that enable healthcare professionals to create a safer environment for their patients. Steris plc consistently strives for excellence, constantly innovating and improving to meet the evolving needs of healthcare providers worldwide. With a strong emphasis on integrity, collaboration, and customer-centricity, Steris plc is dedicated to driving positive changes in healthcare practices and improving outcomes for patients.
Gli analisti fissano attualmente un prezzo obiettivo medio di 271,33 USD per l’azione STERIS plc (mediana: 270,00 USD), pari a +17,3 % rispetto all’ultimo prezzo. Il consenso si basa su 13 giudizi di analisti.
13 analisti valutano attualmente l’azione STERIS plc: 9 raccomandano l’acquisto, 4 la tenuta e 0 la vendita.
Convertita al tasso di cambio attuale, l’azione STERIS plc quota 206,78 EUR (232,35 USD).
L’azione STERIS plc (STE) è quotata su 3 borse, tra cui: NYSE (STE), London (0XI8.L), Frankfurt (2TG.F).
Steris plc is a globally leading company in the field of sterilization and disinfection of medical instruments and facilities. Its business model is based on three main divisions: Healthcare Products, Healthcare Specialty Services, and Life Sciences. Steris offers a wide range of products and services to ensure effective sterilization and disinfection in the medical field. The company is committed to continuous improvement and innovation to meet customer needs. It also prioritizes sustainability and works closely with customers to develop tailored solutions.
Il fatturato di STERIS plc ammonta a 5,94 miliardi USD. Questo dato si basa sui dati finanziari attuali e riflette lo sviluppo commerciale dell'azienda.
Il profitto di STERIS plc ammonta a 785,10 Mio. USD. L'utile netto riflette la redditività dell'azienda dopo la deduzione di tutti i costi.
Il rapporto prezzo/utili (P/E) di STERIS plc è attualmente 28,97. Il rapporto P/E confronta il prezzo attuale dell'azione con l'utile per azione e aiuta gli investitori a valutare la valutazione dell'azione STERIS plc.
Il rapporto prezzo/fatturato (P/S) di STERIS plc è attualmente 3,83. Il rapporto P/S confronta la capitalizzazione di mercato con il fatturato annuo e funge da indicatore di valutazione dell'azione STERIS plc.
Il Quality Score AlleAktien per STERIS plc è 7/10.
L'ISIN di STERIS plc è IE00BFY8C754. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.
Il WKN di STERIS plc è A2PGLV. Il WKN (Wertpapierkennnummer) è un codice identificativo tedesco a sei cifre per i titoli.
Il ticker di STERIS plc è STE. Con questo simbolo di borsa vengono negoziate le azioni STERIS plc in borsa.
Azione STERIS plc
Gruppo di pari di STERIS plc
STERIS plc Ticker
STERIS plc FIGI
Altre metriche e analisi di STERIS plc in Deep Dive.
La nostra analisi azionaria dell'azione STERIS plc include importanti indicatori finanziari come il fatturato, l'utile, il P/E, il P/S, l'EBIT, oltre a informazioni sul dividendo. Inoltre, esaminiamo aspetti come le azioni, la capitalizzazione di mercato, il debito, il patrimonio netto e le passività di STERIS plc. Se state cercando informazioni più dettagliate su questi temi, sulle nostre sottopagine offriamo analisi approfondite: